Related Experiment Videos
[Long-term prognosis of ulcerative colitis]
1Department of Gastroenterology, Showa University Fujigaoka Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 26, 1999
Summary
Ulcerative colitis patients generally have a favorable long-term prognosis with effective treatments. Most patients experience reduced active disease and relapse, maintaining a good quality of life.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Outcomes
Context:
- Ulcerative colitis (UC) management involves intermittent activity and remission periods.
- Salazopyridine and corticosteroid therapies demonstrate efficacy in UC treatment.
- Increasing non-active UC cases correlate with decreasing active disease and relapse rates.
Purpose:
- To evaluate the long-term prognosis and quality of life for ulcerative colitis patients.
- To analyze colectomy rates and indications in Japan.
- To assess the risk of colonic cancer in long-standing total colitis.
Summary:
- Long-term prognosis for ulcerative colitis is favorable due to good response to treatments like salazopyridine and steroids.
- Over 90% of patients with long-term UC can work with minimal daily living limitations.
- Colectomy rates in Japan are relatively low (4.1% at 1 year, 6.8% at 2 years), with surgery primarily for complications or severe disease.
- The risk of colonic cancer, particularly flat, poorly differentiated adenocarcinomas, is elevated in total colitis patients with disease duration exceeding 10 years.
Impact:
- Highlights the positive impact of current therapies on patient quality of life and work capacity.
- Provides data on surgical intervention trends and reasons in ulcerative colitis.
- Emphasizes the critical need for regular colonoscopic surveillance in high-risk patient groups (total colitis >10 years) to detect colonic cancer early.